And related video:
Yuri Deigin, CEO of YouthBio Therapeutics, explores the promising field of partial reprogramming and its potential applications in the brain. Deigin explains his journey as an early advocate for partial reprogramming and its therapeutic possibilities, and discusses how partial reprogramming, a process involving the temporary activation of Yamanaka factors, has gained substantial interest and investment due to its potential to rejuvenate cells and extend lifespan. Deigin highlights various studies demonstrating the effectiveness of partial reprogramming in treating diseases, including Alzheimer’s, and shares his optimism about translating these breakthroughs into clinical therapies.
